251 related articles for article (PubMed ID: 31350989)
21. Delivery of miR-375 and doxorubicin hydrochloride by lipid-coated hollow mesoporous silica nanoparticles to overcome multiple drug resistance in hepatocellular carcinoma.
Xue H; Yu Z; Liu Y; Yuan W; Yang T; You J; He X; Lee RJ; Li L; Xu C
Int J Nanomedicine; 2017; 12():5271-5287. PubMed ID: 28769563
[TBL] [Abstract][Full Text] [Related]
22. A Natural CCR2 Antagonist Relieves Tumor-associated Macrophage-mediated Immunosuppression to Produce a Therapeutic Effect for Liver Cancer.
Yao W; Ba Q; Li X; Li H; Zhang S; Yuan Y; Wang F; Duan X; Li J; Zhang W; Wang H
EBioMedicine; 2017 Aug; 22():58-67. PubMed ID: 28754304
[TBL] [Abstract][Full Text] [Related]
23. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
[TBL] [Abstract][Full Text] [Related]
24. pH-sensitive doxorubicin-loaded polymeric nanocomplex based on β-cyclodextrin for liver cancer-targeted therapy.
Yang T; Du G; Cui Y; Yu R; Hua C; Tian W; Zhang Y
Int J Nanomedicine; 2019; 14():1997-2010. PubMed ID: 30962684
[TBL] [Abstract][Full Text] [Related]
25. Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance.
Guo Y; Chu M; Tan S; Zhao S; Liu H; Otieno BO; Yang X; Xu C; Zhang Z
Mol Pharm; 2014 Jan; 11(1):59-70. PubMed ID: 24229050
[TBL] [Abstract][Full Text] [Related]
26. Silver nanoparticles from Dendropanax morbifera Léveille inhibit cell migration, induce apoptosis, and increase generation of reactive oxygen species in A549 lung cancer cells.
Castro Aceituno V; Ahn S; Simu SY; Wang C; Mathiyalagan R; Yang DC
In Vitro Cell Dev Biol Anim; 2016 Dec; 52(10):1012-1019. PubMed ID: 27251158
[TBL] [Abstract][Full Text] [Related]
27. Carnosic acid induces apoptosis of hepatocellular carcinoma cells via ROS-mediated mitochondrial pathway.
Zhang X; Chen Y; Cai G; Li X; Wang D
Chem Biol Interact; 2017 Nov; 277():91-100. PubMed ID: 28918123
[TBL] [Abstract][Full Text] [Related]
28. 7-O-geranylquercetin-induced autophagy contributes to apoptosis via ROS generation in human non-small cell lung cancer cells.
Wang EX; Zou BY; Shi L; Du LY; Zhu YY; Jiang YM; Ma XD; Kang XH; Wang CY; Zhen YH; Sun LD
Life Sci; 2017 Jul; 180():102-113. PubMed ID: 28495516
[TBL] [Abstract][Full Text] [Related]
29. Calotropis gigantea extract induces apoptosis through extrinsic/intrinsic pathways and reactive oxygen species generation in A549 and NCI-H1299 non-small cell lung cancer cells.
Lee J; Jang HJ; Chun H; Pham TH; Bak Y; Shin JW; Jin H; Kim YI; Ryu HW; Oh SR; Yoon DY
BMC Complement Altern Med; 2019 Jun; 19(1):134. PubMed ID: 31215445
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxicity of withasteroids: withametelin induces cell cycle arrest at G2/M phase and mitochondria-mediated apoptosis in non-small cell lung cancer A549 cells.
Rao PC; Begum S; Jahromi MA; Jahromi ZH; Sriram S; Sahai M
Tumour Biol; 2016 Sep; 37(9):12579-12587. PubMed ID: 27382976
[TBL] [Abstract][Full Text] [Related]
31. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
[TBL] [Abstract][Full Text] [Related]
32. Hepatocyte cytotoxicity evaluation with zinc oxide nanoparticles.
Kim AR; Ahmed FR; Jung GY; Cho SW; Kim DI; Um SH
J Biomed Nanotechnol; 2013 May; 9(5):926-9. PubMed ID: 23802425
[TBL] [Abstract][Full Text] [Related]
33. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
34. Giganteaside D induces ROS-mediated apoptosis in human hepatocellular carcinoma cells through the MAPK pathway.
Liu J; Wei X; Wu Y; Wang Y; Qiu Y; Shi J; Zhou H; Lu Z; Shao M; Yu L; Tong L
Cell Oncol (Dordr); 2016 Aug; 39(4):333-42. PubMed ID: 27016209
[TBL] [Abstract][Full Text] [Related]
35. Low-density lipoprotein decorated silica nanoparticles co-delivering sorafenib and doxorubicin for effective treatment of hepatocellular carcinoma.
Ye J; Zhang R; Chai W; Du X
Drug Deliv; 2018 Nov; 25(1):2007-2014. PubMed ID: 30799656
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of the antiproliferative efficacy of BRM270 phytocomposite nanoparticles against human hepatoma cancer cell lines.
Gera M; Kim N; Ghosh M; Sharma N; Huynh DL; Chandimali N; Koh H; Zhang JJ; Kang TY; Park YH; Kwon T; Jeong DK
Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():166-176. PubMed ID: 30678901
[TBL] [Abstract][Full Text] [Related]
37. Enhanced delivery of sorafenib with anti-GPC3 antibody-conjugated TPGS-b-PCL/Pluronic P123 polymeric nanoparticles for targeted therapy of hepatocellular carcinoma.
Gan H; Chen L; Sui X; Wu B; Zou S; Li A; Zhang Y; Liu X; Wang D; Cai S; Liu X; Liang Y; Tang X
Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():395-403. PubMed ID: 30033270
[TBL] [Abstract][Full Text] [Related]
38. Galactose-Containing Polymer-DOX Conjugates for Targeting Drug Delivery.
Sun Y; Zhang J; Han J; Tian B; Shi Y; Ding Y; Wang L; Han J
AAPS PharmSciTech; 2017 Apr; 18(3):749-758. PubMed ID: 27287244
[TBL] [Abstract][Full Text] [Related]
39. Negative-charge-functionalized mesoporous silica nanoparticles as drug vehicles targeting hepatocellular carcinoma.
Xie M; Xu Y; Shen H; Shen S; Ge Y; Xie J
Int J Pharm; 2014 Oct; 474(1-2):223-31. PubMed ID: 25149125
[TBL] [Abstract][Full Text] [Related]
40. Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer.
Zhu WT; Liu SY; Wu L; Xu HL; Wang J; Ni GX; Zeng QB
Int J Nanomedicine; 2017; 12():2621-2634. PubMed ID: 28435247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
